Skip to content

Alamar Biosciences ALMR Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Construction Partners logo
Construction PartnersROAD
$14.13M+9,784%
Repligen logo
RepligenRGEN
$1.98M-9.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$198.6M+10.6%
TFX
TeleflexTFX
-$3.43M-127%
Advanced Micro Devices logo
Advanced Micro DevicesAMD
$308M+30.0%
CoreWeave, Inc.
 logo
CoreWeave, Inc. CRWV
$471M+291%

Other financials

Income statement

See full
Revenue$26.0M+98.9%
Gross profit$14.5M+126%
Operating income-$12.3M-44.4%
Net income-$21.3M-178%
EPS (diluted)-$1.74-156%

Balance sheet

See full
Cash & equivalents$64.6M
Total debt$30.6M
Total equity-$178.1M
Total assets$186.5M

Cash flow

See full
Operating cash flow-$20.3M-55.7%
CapEx$600.0K+8.3%
Free cash flow-$20.9M-53.8%

Valuation

See full
Market cap$1.52B
Enterprise value$1.49B

Returns & leverage

See full
Debt / equity-0.2×
Current ratio5.9×

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alamar Biosciences 's increase (decrease) in prepaid expense and other assets?
Alamar Biosciences (ALMR) reported increase (decrease) in prepaid expense and other assets of $1.96M in Q1 2026.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.